This Article Full Text Full Text (PDF) Supplemental Data Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pacifico, F. Articles by Leonardi, A. Search for Related Content PubMed PubMed Citation Articles by Pacifico, F. Articles by Leonardi, A. Related Collections Thyroid Endocrine Oncology

RbAp48 is a Target of Nuclear Factor-B Activity in Thyroid Cancer

Istituto di Endocrinologia e Oncologia Sperimentale (F.P., E.C.), Consiglio Nazionale delle Ricerche, 80131 Naples, Italy; Dipartimento di Biologia e Patologia Cellulare e Molecolare (M.P., S.F., A.L.), "Federico II" University of Naples, 80131 Naples, Italy; Functional Genomic Unit (G.C., M.M.), Istituto Nationale Tumori Fondazione G. Pascale, 80131 Naples, Italy; Laboratorio di Proteomica e Spettrometria di Massa (S.A., A.S.), Istituto per il Sistema di Produzione Animale in Ambiente Mediterraneo, Consiglio Nazionale delle Ricerche, 80147 Naples, Italy; and Dipartimento di Scienze e Tecnologie Biomediche (C.V., G.T.), University of Udine, 33100 Udine, Italy

Address all correspondence and requests for reprints to: Antonio Leonardi, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Federico II University of Naples, Via S. Pansini 5, 80131 Naples, Italy. E-mail: leonardi{at}unina.it.

Context: We have recently shown that nuclear factor (NF)-B activity is constitutively elevated in anaplastic human thyroid carcinomas. The inhibition of NF-B in the anaplastic thyroid carcinoma cell line (FRO) leads to increased susceptibility to apoptosis induced by chemotherapeutic drugs and to the block of oncogenic activity.

Objectives: To understand better the molecular mechanisms played by NF-B in thyroid oncogenesis, we performed a differential proteomic analysis between FRO transfected with a superrepressor form of inhibitor of B (IBM) and the parental counterpart (FRO Neo cells).

Results: Differential proteomic analysis revealed that the retinoblastoma-associated protein 48 (RbAp48) is down-regulated in the absence of functional NF-B. Immunohistochemical analysis of normal and pathological human thyroid specimens confirmed that RbAp48 is strongly overexpressed in primary human carcinomas. Reduction of RbAp48 expression using small interfering RNA determined the suppression of tumorigenicity, very likely due to the decrease of their growth rate rather than to an increased susceptibility to apoptosis. In addition, we showed that NF-B, at least in part, transcriptionally controls RbAp 48. A functional NF-B consensus sequence was located within the promoter region of RbAp48 human gene, and embryonic fibroblasts isolated from the p65 knockout mouse (murine embryonic fibroblasts p65^–/–) showed decreased expression of RbAp48.

Conclusion: Our results show that RbAp48 is a NF-B-regulated gene playing an important role in thyroid cancer cell autonomous proliferation.

This article has been cited by other articles:

				R. C Smallridge, L. A Marlow, and J. A Copland Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies Endocr. Relat. Cancer, March 1, 2009; 16(1): 17 - 44. [Abstract] [Full Text] [PDF]